Catalyst Wire Dossier Catalyst Wire Dossier

LITHOSTAT

acetohydroxamic acid · Mission Pharmacal Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LITHOSTAT, covering 2015-01-26 to 2015-01-26. Get the full timeline:

Most recent: FDA Approved: LITHOSTAT — Supplemental Application (Mission Pharmacal Company)

See pricing